Statin therapy in cardiovascular diseases other than atherosclerosis

Dominique Beaudry, Kenneth E. Stone, Suzanne Wetherold, John Hemphill, John McClish, Robert Chilton

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Statins are drugs that inhibit 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, thereby blocking the synthesis of cholesterol. Since being discovered in Japan in the mid 1970s, statins have been widely used to lower low-density lipoprotein cholesterol. However, analysis of cardiovascular research has revealed other important effects beyond changes in lipid parameters, referred to as pleiotropic effects. This paper focuses on the effects of statins as anti-ischemic agents with improvement in endothelial function, along with studies on valvular aortic stenosis, atrial fibrillation, heart failure, peripheral arterial disease, and cancer. As the evolution of statin research continues, there appear to be new potential benefits from statins to be found in many facets of cardiovascular disease.

Original languageEnglish (US)
Pages (from-to)25-32
Number of pages8
JournalCurrent atherosclerosis reports
Issue number1
StatePublished - Jan 2007

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Statin therapy in cardiovascular diseases other than atherosclerosis'. Together they form a unique fingerprint.

Cite this